Table 1 Patient characteristics and PET parameters distribution
From: Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma
Characteristics | 164 patients | |
|---|---|---|
Median age(range) | 65(36–85 years) | |
Sex | Male | 72(43.90%) |
Female | 92(56.10%) | |
Stage | IA | 84(51.22%) |
IB | 43(26.22%) | |
IIA | 10(6.10%) | |
IIB | 13(7.93%) | |
IIIA | 14(8.54%) | |
T Stage | T1 | 93(56.71%) |
T2 | 55(33.54%) | |
T3 | 7(4.27%) | |
T4 | 9(5.49%) | |
N Stage | N0 | 141(85.98%) |
N1 | 14(8.54%) | |
N2 | 9(5.49%) | |
Operation | Lobectomy | 116(70.73%) |
Segmentectomy | 16(10.37%) | |
Sublobar resection | 25(18.90%) | |
Adjuvant Therapy | No | 143(87.20%) |
Chemotherapy | 16(9.76%) | |
Targeted Therapy | 5(3.05%) | |
CEA | 11.59 ± 30.49 | |
SUVmax | 6.54 ± 4.62 | |
TLG | 25.68 ± 76.45 | |
MTV | 5.43 ± 10.61 | |
NHOCmax | 0.55 ± 0.28 | |
NHOPmax | 0.34 ± 0.23 |